doi: 10.3390/ijms232314631, Summary Keywords GLP-1/GIP dual agonist, metabolic regulation, obesity, obstructive sleep apnea, tirzepatide Citation Fang Q, Zhu Y, Rao M and Liu P (2026) GLP-1/GIP dual agonist tirzepatide in obstructive sleep apnea syndrome: mechanisms, evidence, and clinical perspectives
Type 2 diabetes mellitus most often develops due to disorders of carbohydrate metabolism
The benefits of a combined therapy have been confirmed in a few retrospective cohort studies
Ann Oncol (2017) 28(suppl_8):viii17
We also discussed HMO science advances with Novonesis, as emerging research has sparked renewed interest in these compounds for systemic health benefits
Individuals with autism not only demonstrate decreased glutathione levels but also show deficiencies in other transsulfuration metabolites such as taurine, sulfate, and cysteine